Viewing StudyNCT05743335



Ignite Creation Date: 2024-05-06 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05743335
Status: COMPLETED
Last Update Posted: 2023-03-17
First Post: 2023-02-22

Brief Title: A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221 an MRNA-based Broadly Protective COVID-19 Vaccine
Sponsor: Immorna Biotherapeutics Inc
Organization: Immorna Biotherapeutics Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-20
Start Date Type: ESTIMATED
Primary Completion Date: 2024-09-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-10-04
Completion Date Type: ESTIMATED
First Submit Date: 2023-02-22
First Submit QC Date: February 22 2023
Study First Post Date: 2023-02-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-09
Last Update Post Date: 2023-03-17
Last Update Post Date Type: ACTUAL